Civic Intelligence

Global Vaccines Inc

EIN 65-1161833 • 501(c)3 • Chapel Hill, NC

View Organization Page

Profile

To facilitate the design,development, manufacture and distribution

408 Dragonfly TrailChapel Hill, NC 27517

www.globalvaccines.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

89th percentile

0.43x

Higher debt load relative to assets than 89% of similar nonprofits.

NTEE G • <$500k nonprofits • Source year 2024

Liabilities / Revenue

97th percentile

1.43x

Higher debt load relative to revenue than 97% of similar nonprofits.

NTEE G • <$500k nonprofits • Source year 2024

Net Margin

91st percentile

79%

Higher net margin than 91% of similar nonprofits.

NTEE G • <$500k nonprofits • Source year 2024

Top Officer Pay

87th percentile

$0

Higher top officer pay than 87% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

NTEE G • <$500k nonprofits • Source year 2024

Asset Growth

75th percentile

28%

Faster asset growth than 75% of similar nonprofits.

NTEE G • <$500k nonprofits • Annualized from 2023 to 2024

Revenue Growth

51st percentile

1.9%

Faster revenue growth than 51% of similar nonprofits.

NTEE G • <$500k nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / Assets89th percentile

Assets

Up

$170,069

Up $37,220 (+28%) from 2023

Liabilities

Down

$72,858

Down $2,816 (-3.7%) from 2023

Net Assets

Up

$97,211

Up $40,036 (+70%) from 2023

Operations
Liabilities / Revenue97th percentileNet Margin91st percentile

Revenue

Up

$51,000

Up $962 (+1.9%) from 2023

Expenses

Up

$10,964

Up $4,432 (+68%) from 2023

Net Income

Down

$40,036

Down $3,470 (-8.0%) from 2023

Trend Graphs

Balance Sheet Trend

Asset Growth75th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$1.0M$500K$0-$500K-$1.0MAssets 2010: $574,063Liabilities 2010: $605,641Net Assets 2010: -$31,5782010Assets 2011: $229,805Liabilities 2011: $948,772Net Assets 2011: -$718,9672011Assets 2012: $340,287Liabilities 2012: $948,262Net Assets 2012: -$607,9752012Assets 2013: $146,489Liabilities 2013: $295,976Net Assets 2013: -$149,4872013Assets 2014: $189,911Liabilities 2014: $248,001Net Assets 2014: -$58,0902014Assets 2015: $200,274Liabilities 2015: $220,536Net Assets 2015: -$20,2622015Assets 2016: $100,757Liabilities 2016: $199,448Net Assets 2016: -$98,6912016Assets 2017: $54,630Liabilities 2017: $198,344Net Assets 2017: -$143,7142017Assets 2018: $25,648Liabilities 2018: $202,342Net Assets 2018: -$176,6942018Assets 2019: $1,088Liabilities 2019: $202,882Net Assets 2019: -$201,7942019Assets 2020: $1,322Liabilities 2020: $231,540Net Assets 2020: -$230,2182020Assets 2021: $100,908Liabilities 2021: $107,077Net Assets 2021: -$6,1692021Assets 2022: $99,742Liabilities 2022: $207,793Net Assets 2022: -$108,0512022Assets 2023: $132,849Liabilities 2023: $75,674Net Assets 2023: $57,1752023Assets 2024: $170,069Liabilities 2024: $72,858Net Assets 2024: $97,2112024

Highlighted filing

2024

Assets$170,069
Liabilities$72,858
Net Assets$97,211
Open 2024 Filing

Operations Trend

Revenue Growth51st percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$3.0M$2.0M$1.0M$0-$1.0MRevenue 2010: $2,235,487Expenses 2010: $2,589,026Net Income 2010: -$353,5392010Revenue 2011: $1,707,895Expenses 2011: $2,395,284Net Income 2011: -$687,3892011Expenses 2012: $2,261,2402012Revenue 2013: $1,437,518Expenses 2013: $1,437,468Net Income 2013: $502013Revenue 2014: $900,307Expenses 2014: $824,458Net Income 2014: $75,8492014Revenue 2015: $547,540Expenses 2015: $529,268Net Income 2015: $18,2722015Revenue 2016: $131,427Expenses 2016: $209,856Net Income 2016: -$78,4292016Revenue 2017: $249Expenses 2017: $45,272Net Income 2017: -$45,0232017Revenue 2018: $15,337Expenses 2018: $48,317Net Income 2018: -$32,9802018Revenue 2019: $5,594Expenses 2019: $30,694Net Income 2019: -$25,1002019Revenue 2020: $968Expenses 2020: $29,392Net Income 2020: -$28,4242020Revenue 2021: $235,871Expenses 2021: $11,822Net Income 2021: $224,0492021Revenue 2022: $45,075Expenses 2022: $25,237Net Income 2022: $19,8382022Revenue 2023: $50,038Expenses 2023: $6,532Net Income 2023: $43,5062023Revenue 2024: $51,000Expenses 2024: $10,964Net Income 2024: $40,0362024

Highlighted filing

2024

Revenue$51,000
Expenses$10,964
Net Income$40,036
Open 2024 Filing

Filings

Most recent year

2024 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$170,069
Liabilities
$72,858
Net assets
$97,211
Revenue
$51,000
Expenses
$10,964
Net income
$40,036
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$0.17$0.07$0.10$0.05$0.01$0.04
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.13$0.08$0.06$0.05$0.01$0.04
2022Detailed filing. Detailed filing data is available for this year.$0.10$0.21$0.11$0.05$0.03$0.02
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.10$0.11$0.01$0.24$0.01$0.22
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.00$0.23$0.23$0.00$0.03$0.03
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.00$0.20$0.20$0.01$0.03$0.03
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.03$0.20$0.18$0.02$0.05$0.03
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.05$0.20$0.14$0.00$0.05$0.05
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.10$0.20$0.10$0.13$0.21$0.08
2015Detailed filing. Detailed filing data is available for this year.$0.20$0.22$0.02$0.55$0.53$0.02
2014Detailed filing. Detailed filing data is available for this year.$0.19$0.25$0.06$0.90$0.82$0.08
2013Detailed filing. Detailed filing data is available for this year.$0.15$0.30$0.15$1.44$1.44$0.00
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.34$0.95$0.61$2.26
2011Summary only. Only limited summary data is available for this year.$0.23$0.95$0.72$1.71$2.40$0.69
2010Summary only. Only limited summary data is available for this year.$0.57$0.61$0.03$2.24$2.59$0.35
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Oct 31, 2025
Return Version
2024v5.2
Gross Receipts
$51,000
Mission and Program Overview

Mission

To facilitate the design,

Vaccine Development & Research

Program Services

DescriptionGrantsExpenses
The organization has continued to develop utilization of its lead product, a vaccine adjuvant which enhances the humoral, cellular, and mucosal immunity raised by a given vaccine.-$10,964
Compensation and Service Providers
Top Officer Pay87th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Robert E JohnstonExecutive Director-$0--
Joseph S Pagano MDChair Of The Board-$0--
William Bunch CPABoard Member-$0--
Kelly T McKeeBoard Member-$0--
Filing and Contact Details

Filer

Filer Name
Global Vaccines Inc
EIN
65-1161833
In Care Of
% Robert E Johnston
Phone
9194185535
Address
408 Dragonfly Trail, Chapel Hill, NC 27517

Signing Officer

Name
Robert E Johnston Phd
Title
Executive Director
Phone
9194185535
Signed
2025-10-31
Discuss with paid preparer
Yes

Preparer

Firm
Camille Parker CPA PLLC
Address
8801 Fast Park Drive Suite 301, Raleigh, NC 27617
Preparer
Camille Parker
Phone
9198615241
Supplemental Narrative

Additional Explanations

Description of other expenses Part I line 16

“Description AmountInterest Expense 1,291Insurance 975Patent Expense 6,743Website Fees 140”

Description of other assets Part II line 24

“Category Beginning of Year End of YearPrepaid License Fees 14 1,680Accounts Receivables 45,000 84,000Note Receivable 85,000 80,000”

Description of total liabilities Part II line 26

“Category Beginning of Year End of YearAccounts Payable 46,258 45,879Accrued Interest Payable 1,137 1,136Officer Short Term Loan 14,930 14,930Credit Card Payable 13,349 10,913”

Raw XML Appendix155 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0Robert E Johnston PHD
IRS990EZ/BooksInCareOfDetail/PhoneNum09194185535
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt0408 Dragonfly Trail
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0Chapel Hill
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NC
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd027517
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt02835
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt04389
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt01000
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt040036
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt01815
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0132849
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0170069
IRS990EZ/GrossReceiptsAmt051000
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/LandAndBuildingsGrp/BOYAmt00
IRS990EZ/LandAndBuildingsGrp/EOYAmt00
IRS990EZ/LoansToFromOfficersAmt014930
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0true
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt057175
IRS990EZ/NetAssetsOrFundBalancesEOYAmt097211
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt057175
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt097211
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt01.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt10.50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt20.50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt30.50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0Robert E Johnston
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Joseph S Pagano MD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2William Bunch CPA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3Kelly T McKee
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0Executive Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Chair of the Board
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Board Member
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Board Member
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherAssetsTotalDetail/BOYAmt0130014
IRS990EZ/OtherAssetsTotalDetail/EOYAmt0165680
IRS990EZ/OtherExpensesTotalAmt09149
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0Vaccine Development & Research
IRS990EZ/ProgramServiceRevenueAmt050000
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0The organization has continued to develop utilization of its lead product, a vaccine adjuvant which enhances the humoral, cellular, and mucosal immunity raised by a given vaccine.
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt010964
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0NC
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt075674
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt072858
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt010964
IRS990EZ/TotalProgramServiceExpensesAmt010964
IRS990EZ/TotalRevenueAmt051000
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt01000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt038
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt010075
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt0546
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt0968
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt012627
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt01
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt01
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt0370324
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.99990
IRS990ScheduleA/PublicSupportPY170Pct00.99990
IRS990ScheduleA/PublicSupportTotal170Amt012627
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt01000
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt038
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt010075
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt0546
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt0968
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt012627
IRS990ScheduleA/TotalSupportAmt012628
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt014930
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd0true
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanPurposeTxt0Cash Flow
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd0X
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt07930
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/PersonNm0Robert E Johnston
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/RelationshipWithOrgTxt0Executive Director
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd0false
IRS990ScheduleL/TotalBalanceDueAmt014930
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Description AmountInterest Expense 1,291Insurance 975Patent Expense 6,743Website Fees 140
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1Category Beginning of Year End of YearPrepaid License Fees 14 1,680Accounts Receivables 45,000 84,000Note Receivable 85,000 80,000
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2Category Beginning of Year End of YearAccounts Payable 46,258 45,879Accrued Interest Payable 1,137 1,136Officer Short Term Loan 14,930 14,930Credit Card Payable 13,349 10,913
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Description of other expenses Part I line 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Description of other assets Part II line 24
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Description of total liabilities Part II line 26
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0ROBERT E JOHNSTON PHD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0Executive Director
ReturnHeader/BusinessOfficerGrp/PhoneNum09194185535
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-10-31
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0Global Vaccines Inc
ReturnHeader/Filer/BusinessNameControlTxt0GLOB
ReturnHeader/Filer/EIN0651161833
ReturnHeader/Filer/InCareOfNm0% Robert E Johnston
ReturnHeader/Filer/PhoneNum09194185535
ReturnHeader/Filer/USAddress/AddressLine1Txt0408 Dragonfly Trail
ReturnHeader/Filer/USAddress/CityNm0Chapel Hill
ReturnHeader/Filer/USAddress/StateAbbreviationCd0NC
ReturnHeader/Filer/USAddress/ZIPCd027517
ReturnHeader/IRSResponsiblePrtyInfoCurrInd0true
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0455271530
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0Camille Parker CPA PLLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt08801 Fast Park Drive Suite 301
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0Raleigh
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0NC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd027617
ReturnHeader/PreparerPersonGrp/PhoneNum09198615241
ReturnHeader/PreparerPersonGrp/PreparationDt02025-10-31
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0CAMILLE PARKER
ReturnHeader/PreparerPersonGrp/SelfEmployedInd0X
ReturnHeader/ReturnTs02025-10-31T16:40:59-04:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.